It is a financial services private limited company based in Kolkata, West Bengal, India, established in 1984.
1984 | Kolkata, West Bengal, India | ActiveNirmal Drugs Pvt Ltd, a active private limited company, was established on 21 June 1984 in Kolkata, West Bengal, India. Engaging in real estate financing within the trade sector, it holds CIN: U85195WB1984PTC037620. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.55 M.
It upholds a compliant status. Its leadership includes Anand Kumar Luharuka (Director), Madhu Luharuka (Director). Past directors included Rajesh Goenka, Ashok Bhat, Narayan Kumar Loharuka. It holds ₹7.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4 Canal West Road, Kolkata, West Bengal, 700015.
U85195WB1984PTC037620
037620
21 June 1984
₹2.50 M
₹0.55 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Nirmal Drugs Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Kumar Luharuka | Director | 03 Sep 2008 | Current |
| Madhu Luharuka | Director | 01 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jan 2009 | Past |
| Pramod Abcsdd | Director | 09 Jan 2009 | Past |
| Pramod Abcsdd | Director | 01 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nirmal Drugs Pvt Ltd, for the financial year ended 2019, experienced Minor drop in revenue, with a 2.57% decrease. The company also saw a substantial improvement in profitability, with a 127.88% increase in profit. The company's net worth moved up by a moderate rise of 0.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Nirmal Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 1989 | Canara Bank | ₹2.50 M | Open |
| 22 Nov 1988 | Canara Bank | ₹2.50 M | Open |
| 01 Jan 1986 | Canara Bank | ₹1.00 M | Open |
| 19 Dec 1985 | Canara Bank | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nirmal Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nirmal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirmal Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nirmal Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Nirmal Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
The activity Madhu Luharuka was appointed as a Director was appointed as a Director on 01 Mar 2017 & has been associated with this company since 8 years 9 months . was completed.
The activity Anand Kumar Luharuka was appointed as a Director was appointed as a Director on 03 Sep 2008 & has been associated with this company since 17 years 2 months . was completed.
The activity A charge with Canara Bank amounted to Rs. 2.50 M with Charge ID 90246797 was registered on 10 Jul 1989. was completed.
Progress on A charge with Canara Bank of Rs. 2.50 M registered on 22 Nov 1988 with Charge ID 90246794 was modified on 10 Jul 1989. was documented.
The CIN of Nirmal Drugs Pvt Ltd is U85195WB1984PTC037620.
Nirmal Drugs Pvt Ltd is headquartered at 4 Canal West Road, Kolkata, West Bengal, 700015.
Nirmal Drugs Pvt Ltd was incorporated on 21 June 1984.
The current directors of Nirmal Drugs Pvt Ltd are
The primary industry of Nirmal Drugs Pvt Ltd is Trade.
Nirmal Drugs Pvt Ltd is unlisted.
The authorized capital of Nirmal Drugs Pvt Ltd is ₹2.50 M, and the paid-up capital is ₹0.55 M.
The compliance status of Nirmal Drugs Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX